跳至主要内容
临床试验/NCT05726344
NCT05726344已完成不适用

Lactulose vs. Polyethylene Glycol as Bowel Preparation for Colonoscopy in Adults

Hospital de Clínicas Dr. Manuel Quintela1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2023年2月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
150
试验地点
1
主要终点
Compare lactulose vs. Polyethylene Glycol as bowel cleansing preparation for colonoscopy

研究概览

简要总结

Colonoscopy is the gold standard in bowel assessment when there is suspicion of colon and rectum pathology. Bowel cleansing is necessary to ensure an optimal visualization of colonic mucosa, allowing this form of detection and removal of polyps. Nowadays international recommendations have multiple bowel preparations. There are differences among them regarding adherence, tolerance and adverse effects. Lactulose (LAC) is widely used in treating constipation. However, there are some randomized clinical assays using LAC as bowel preparation with excellent results according to bowel preparation and tolerance scales. Adherence to bowel preparation significantly affects the result in the endoscopic study.

Safety of polyethylene glycol (PEG) formulations has been validated in several studies, it presents little severe side effects and the advantage of its applicability to patients with several comorbidities (heart, liver and kidney without water deprivation). However, its main disadvantage lies in the need to ingest large amounts of liquid (3-4L), generating intolerance thereto in 15%-45% of patients.

Bowel cleansing preparation with PEG is widely used in clinical practice. Considering that according to international studies reporting better tolerance and adherence with LAC; it is suggested to compare the level of bowel preparation, tolerance and adherence between two groups with LAC and PEG.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Care Provider, Investigator, Outcomes Assessor)

盲法说明

Triple blind (endoscopist, researchers and statistician) randomized clinical assay.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients over 18 years with no bowel surgical procedures

排除标准

  • Patients willingly deciding not to enter into the study
  • Pregnant women
  • Patient with colonic resections and/or ileostomies
  • Inflammatory bowel disease
  • Colonic optimization by prior colonoscopy with poor preparation
  • Suspected intestinal occlusion or perforation, intussusception
  • Patient with melenas
  • Oral iron intake in the past 10 days
  • Emergency colonoscopy
  • Hypersensitivity to any of the components comprised in preparations.
  • Diabetics
  • Chronic kidney disease in dialysis
  • Uncorrected severe dystonias
  • Severe psychiatric illness (schizophrenia)
  • Low IQ to understand bowel preparation
  • Severe constipation (< 1 weekly stool)
  • Chronic diarrhea with high rate (≥ 4 daily evenly loose consistency stools for more than 4 weeks)
  • Unbalanced heart diseases (ischemic cardiopathology, congestive heart failure, unstable angina, arrhythmias and untreatable high blood pressure)

研究组 & 干预措施

Lactulose group

Experimental

Patients participating in the study shall go on with their usual diet prior to colonoscopy. Three days before avoid consuming fruits, vegetables, seeds and cereals. A low residue soft and liquid diet is allowed.

The day before the study, the group receiving lactulose shall take 4 tablets of Bisacodyl (5 mg) the day before the study at 6pm. Then, at 8pm a bottle of 250 mL (162.5g lactulose) of lactulose shall be dissolved in 600 mL of water and all contents (850 mL) shall be taken in 2 hours. At 10pm they have to drink 2 liters still water.

干预措施: Lactulose (Drug)

Polyethylene glycol group

Experimental

Patients participating in the study shall go on with their usual diet prior to colonoscopy. Three days before avoid consuming fruits, vegetables, seeds and cereals. A low residue soft and liquid diet is allowed.

The day before the study, the group receiving polyethylene glycol (PEG) should take 4 tablets of Bisacodyl (5 mg) at 4pm. Then, at 6pm, 3 bottles of PEG (Polyethylene glycol 3350 60 g; sodium chloride 1.46 g; potassium chloride 745 mg; Sodium bicarbonate 1.68 g; anhydrous sodium sulfate 5.68 g; pineapple flavoring 483 mg) shall be dissolved in 3 liters of water (1 bottle per liter) and they shall take half the preparation, that is 1 liter and a half in 2 hours. At 10pm they shall take the remaining contents in 2 hours.

干预措施: Polyethylene Glycol 3350 (Drug)

结局指标

主要结局

Compare lactulose vs. Polyethylene Glycol as bowel cleansing preparation for colonoscopy

时间窗: 6 months

Compare the level of bowel preparation (by Boston Bowel Preparation Scale) between two groups with lactulose and Polyethylene Glycol. The minimum and maximum value is 0 and 9, respectively. A proper preparation is consider a Boston Bowel Preparation Scale ≥ 2 scores in each colonic segment. Unsuitable preparation a Boston Bowel Preparation Scale \< 2 scores in any of the segments. Score 0: is considered a segment of unprepared colon with mucosa that cannot be observed given the presence of solid stool which does not disappear after cleansing. Score 1: part of the colonic mucosa is observed; other areas cannot be suitably assessed given the presence of staining, residual matter and/or opaque liquid. Score 2: little remaining residual matter and small matter fragments which do not prevent correct visualization of colonic mucosa in said segment. Score 3: colonic mucosa which can be entirely observed with no residual matter nor small fragments of matter and opaque liquid.

Establish Boston Bowel Preparation Scale inter and intra-observer variability

时间窗: 7 months

Two researchers shall review the endoscopic study videos and they shall complete the Boston Bowel Preparation Scale inter-observer questionnaire. Results obtained by the endoscopist in charge of the study and the observers shall be compared so as to establish inter-observer variability. Researchers shall analyze one month later again all colonoscopies recorded thus establishing Boston Bowel Preparation Scale of each endoscopy. Then results previously established shall be compared so as to establish intra-observer variability. The minimum and maximum value is 0 and 9, respectively. A proper preparation is consider a Boston Bowel Preparation Scale ≥ 2 scores in each colonic segment. Unsuitable preparation a Boston Bowel Preparation Scale \< 2 scores in any of the segments.

次要结局

  • Assess tolerance between lactulose and Polyethylene Glycol.(6 months)
  • Establish colonoscopy global adenoma detection rate with lactulose and Polyethylene Glycol.(6 months)
  • Assess adherence between lactulose and Polyethylene Glycol.(6 months)
  • Assess side effects between lactulose and Polyethylene Glycol.(6 months)
  • Establish colonoscopy cecal intubation rate in with lactulose and Polyethylene Glycol.(6 months)

研究者

发起方
Hospital de Clínicas Dr. Manuel Quintela
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ignacio Moratorio

Principal Investigator

Hospital de Clínicas Dr. Manuel Quintela

研究点 (1)

Loading locations...

相似试验

Lactulose vs. Polyethylene Glycol as Bowel... | 临床试验